Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
Trifirò G, Isgrò V, Ingrasciotta Y, Ientile V, L'Abbate L, Foti SS, Belleudi V, Poggi F, Fontana A, Moretti U, Lora R, Sabaini A, Senesi I, Sorrentino C, Puzo MR, Padula A, Fusco M, Giordana R, Solfrini V, Puccini A, Rossi P, Del Zotto S, Leoni O, Zanforlini M, Ancona D, Bavaro V, Garau D, Ledda S, Scondotto S, Allotta A, Tuccori M, Gini R, Bucaneve G, Franchini D, Cavazzana A, Biasi V, Spila Alegiani S, Massari M; VALORE Project Collaborators. Trifirò G, et al. Among authors: moretti u. BioDrugs. 2021 Nov;35(6):749-764. doi: 10.1007/s40259-021-00498-3. Epub 2021 Oct 12. BioDrugs. 2021. PMID: 34637126 Free PMC article.
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project).
Rosa AC, Finocchietti M, Agabiti N, Menè P, Bracaccia ME, Bellini A, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Ferroni E, Pierobon S, Nordio M, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Rosa AC, et al. BMC Nephrol. 2023 Oct 27;24(1):320. doi: 10.1186/s12882-023-03325-9. BMC Nephrol. 2023. PMID: 37891504 Free PMC article.
Adverse events following Measles-Mumps-Rubella and varicella immunization: A safety profile analysis and comparison of different vaccination schedules based on the Italian Pharmacovigilance Network in the Veneto Region.
Soriolo N, Benoni R, Dalla Valle D, Zunino F, Olivieri A, Campagna I, Tardivo S, Augusta Gonella L, Russo F, Tonon M, Da Re F, Moretti U, Zanoni G, Moretti F. Soriolo N, et al. Among authors: moretti u. Prev Med Rep. 2024 Mar 29;41:102711. doi: 10.1016/j.pmedr.2024.102711. eCollection 2024 May. Prev Med Rep. 2024. PMID: 38606113 Free PMC article.
Development, assessment and educational impact of a blended e-learning training program on pharmacovigilance implemented in four African countries.
Schievano F, Mwamwitwa KW, Kisenge S, Mmari E, Duga A, Nhlabatsi S, Elagbaje C, Abiola AS, Meshesha SG, Pagani S, Lora R, Sabaini A, Cobelens F, Härmark L, Eko EB, Conforti A, Venegoni M, Magro L, Moretti U. Schievano F, et al. Among authors: moretti u. Front Med (Lausanne). 2024 Apr 17;11:1347317. doi: 10.3389/fmed.2024.1347317. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38695021 Free PMC article.
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports.
Crescioli G, Maggini V, Raschi E, Gonella LA, Luxi N, Ippoliti I, Di Giovanni V, Bonaiuti R, Firenzuoli N, Gallo E, Menniti-Ippolito F, Moretti U, Trifirò G, Vannacci A, Firenzuoli F, Lombardi N. Crescioli G, et al. Among authors: moretti u. Phytother Res. 2023 Nov;37(11):5289-5299. doi: 10.1002/ptr.7960. Epub 2023 Jul 18. Phytother Res. 2023. PMID: 37463655
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials.
Ahmadizar F, Luxi N, Raethke M, Schmikli S, Riefolo F, Saraswati PW, Bucsa C, Osman A, Liddiard M, Maques FB, Petrelli G, Sonderlichová S, Thurin NH, Villalobos F, Trifirò G, Sturkenboom M; ilmiovaccinoCOVID19 collaborating group. Ahmadizar F, et al. Drug Saf. 2023 Jun;46(6):575-585. doi: 10.1007/s40264-023-01304-5. Epub 2023 Apr 27. Drug Saf. 2023. PMID: 37103643 Free PMC article.
Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.
Menniti-Ippolito F, Aiello E, Arzenton E, Assisi A, Blaznik U, Castenmiller JJM, Crevani M, de Clock D, Di Giacomo S, Emendi S, Gonella LA, Ippoliti I, Lindquist M, Magro L, Mazzanti G, Mores N, Moretti U, Moro PA, Novakovic B, Raschi E, Siksna I, Valetto MR, Vitalone A, Vo Van Regnault G. Menniti-Ippolito F, et al. Among authors: moretti u. Drug Saf. 2023 May;46(5):435-437. doi: 10.1007/s40264-023-01284-6. Epub 2023 Apr 6. Drug Saf. 2023. PMID: 37022637 No abstract available.
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System.
Crisafulli S, Cutroneo PM, Luxi N, Fontana A, Ferrajolo C, Marchione P, Sottosanti L, Zanoni G, Moretti U, Franzè S, Minghetti P, Trifirò G. Crisafulli S, et al. Among authors: moretti u. Drug Saf. 2023 Apr;46(4):343-355. doi: 10.1007/s40264-023-01277-5. Epub 2023 Feb 15. Drug Saf. 2023. PMID: 36790561 Free PMC article.
106 results